Shares of Ondine Biomedical Inc. (LON:OBI – Get Free Report) rose 33.3% during mid-day trading on Tuesday . The company traded as high as GBX 8.24 ($0.11) and last traded at GBX 7.50 ($0.10). Approximately 506,731 shares traded hands during trading, an increase of 93% from the average daily volume of 262,873 shares. The stock had previously closed at GBX 5.63 ($0.08).
Ondine Biomedical Price Performance
The company has a debt-to-equity ratio of 25.95, a current ratio of 1.36 and a quick ratio of 8.26. The firm has a market capitalization of £19.41 million, a P/E ratio of -140.63 and a beta of 0.10. The company’s 50 day moving average price is GBX 7.28 and its 200 day moving average price is GBX 7.58.
Ondine Biomedical Company Profile
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
See Also
- Five stocks we like better than Ondine Biomedical
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- The Average 401k Balance by Age Explained
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- Why Are These Companies Considered Blue Chips?
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
